"","target","p","padj"
"Antiviral Agents","Antiviral Agents",0.002,0.246
"Antineoplastic Agents","Antineoplastic Agents",0.022,1
"Radiation-Sensitizing Agents","Radiation-Sensitizing Agents",0.022,1
"Protein Synthesis Inhibitors","Protein Synthesis Inhibitors",0.023,1
"Immunosuppressive Agents","Immunosuppressive Agents",0.028,1
"Antihypertensive Agents","Antihypertensive Agents",0.034,1
"Antifungal Agents","Antifungal Agents",0.052,1
"Enzyme Inhibitors","Enzyme Inhibitors",0.052,1
"Estrogen Antagonists","Estrogen Antagonists",0.065,1
"Histone Deacetylase Inhibitors","Histone Deacetylase Inhibitors",0.069,1
"Phosphodiesterase Inhibitors","Phosphodiesterase Inhibitors",0.069,1
"Antineoplastic Agents, Alkylating","Antineoplastic Agents, Alkylating",0.073,1
"Amebicides","Amebicides",0.088,1
"Emetics","Emetics",0.088,1
"Cytochrome P-450 CYP3A Inducers","Cytochrome P-450 CYP3A Inducers",0.103,1
"Bone Density Conservation Agents","Bone Density Conservation Agents",0.109,1
"Selective Estrogen Receptor Modulators","Selective Estrogen Receptor Modulators",0.109,1
"Antitubercular Agents","Antitubercular Agents",0.128,1
"Immunologic Factors","Immunologic Factors",0.128,1
"Protease Inhibitors","Protease Inhibitors",0.128,1
"Voltage-Gated Sodium Channel Blockers","Voltage-Gated Sodium Channel Blockers",0.154,1
"Adrenergic Uptake Inhibitors","Adrenergic Uptake Inhibitors",0.159,1
"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",0.174,1
"Neuroprotective Agents","Neuroprotective Agents",0.18,1
"Adrenergic alpha-1 Receptor Antagonists","Adrenergic alpha-1 Receptor Antagonists",0.184,1
"Teratogens","Teratogens",0.193,1
"Coloring Agents","Coloring Agents",0.198,1
"Anti-Ulcer Agents","Anti-Ulcer Agents",0.199,1
"Calcium Channel Blockers","Calcium Channel Blockers",0.207,1
"Diuretics","Diuretics",0.231,1
"Sodium Chloride Symporter Inhibitors","Sodium Chloride Symporter Inhibitors",0.231,1
"Adrenergic alpha-2 Receptor Agonists","Adrenergic alpha-2 Receptor Agonists",0.236,1
"Antidepressive Agents, Tricyclic","Antidepressive Agents, Tricyclic",0.236,1
"Sympatholytics","Sympatholytics",0.236,1
"Antidepressive Agents, Second-Generation","Antidepressive Agents, Second-Generation",0.24,1
"Antiprotozoal Agents","Antiprotozoal Agents",0.249,1
"Serotonin Antagonists","Serotonin Antagonists",0.258,1
"Estrogens","Estrogens",0.26,1
"Antineoplastic Agents, Hormonal","Antineoplastic Agents, Hormonal",0.3,1
"Cathartics","Cathartics",0.311,1
"Anti-Inflammatory Agents","Anti-Inflammatory Agents",0.32,1
"Cysteine Proteinase Inhibitors","Cysteine Proteinase Inhibitors",0.332,1
"Protein Kinase Inhibitors","Protein Kinase Inhibitors",0.338,1
"Anti-Anxiety Agents","Anti-Anxiety Agents",0.353,1
"Anticarcinogenic Agents","Anticarcinogenic Agents",0.361,1
"Adjuvants, Immunologic","Adjuvants, Immunologic",0.374,1
"Anti-Arrhythmia Agents","Anti-Arrhythmia Agents",0.388,1
"Phosphodiesterase 5 Inhibitors","Phosphodiesterase 5 Inhibitors",0.388,1
"Urological Agents","Urological Agents",0.388,1
"Platelet Aggregation Inhibitors","Platelet Aggregation Inhibitors",0.393,1
"Anti-Bacterial Agents","Anti-Bacterial Agents",0.421,1
"Antipsychotic Agents","Antipsychotic Agents",0.422,1
"Antitussive Agents","Antitussive Agents",0.426,1
"Adrenergic beta-2 Receptor Agonists","Adrenergic beta-2 Receptor Agonists",0.427,1
"Sympathomimetics","Sympathomimetics",0.427,1
"Tocolytic Agents","Tocolytic Agents",0.427,1
"Cytochrome P-450 CYP1A2 Inhibitors","Cytochrome P-450 CYP1A2 Inhibitors",0.428,1
"Antimetabolites, Antineoplastic","Antimetabolites, Antineoplastic",0.432,1
"Anti-HIV Agents","Anti-HIV Agents",0.433,1
"Nucleic Acid Synthesis Inhibitors","Nucleic Acid Synthesis Inhibitors",0.434,1
"Vasodilator Agents","Vasodilator Agents",0.444,1
"Gastrointestinal Agents","Gastrointestinal Agents",0.459,1
"Cytochrome P-450 CYP2C9 Inhibitors","Cytochrome P-450 CYP2C9 Inhibitors",0.46,1
"Cytochrome P-450 CYP2D6 Inhibitors","Cytochrome P-450 CYP2D6 Inhibitors",0.46,1
"Cytochrome P-450 CYP3A Inhibitors","Cytochrome P-450 CYP3A Inhibitors",0.46,1
"Potassium Channel Blockers","Potassium Channel Blockers",0.46,1
"Keratolytic Agents","Keratolytic Agents",0.461,1
"Calcineurin Inhibitors","Calcineurin Inhibitors",0.483,1
"Anticonvulsants","Anticonvulsants",0.502,1
"Adrenergic alpha-Antagonists","Adrenergic alpha-Antagonists",0.519,1
"Coccidiostats","Coccidiostats",0.519,1
"Histamine H1 Antagonists","Histamine H1 Antagonists",0.519,1
"Progestins","Progestins",0.523,1
"Adrenergic alpha-1 Receptor Agonists","Adrenergic alpha-1 Receptor Agonists",0.525,1
"Nasal Decongestants","Nasal Decongestants",0.525,1
"Vasoconstrictor Agents","Vasoconstrictor Agents",0.525,1
"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",0.527,1
"Bronchodilator Agents","Bronchodilator Agents",0.539,1
"Dopamine Antagonists","Dopamine Antagonists",0.542,1
"Glucocorticoids","Glucocorticoids",0.545,1
"Antioxidants","Antioxidants",0.552,1
"Alkylating Agents","Alkylating Agents",0.558,1
"Cross-Linking Reagents","Cross-Linking Reagents",0.558,1
"Antiemetics","Antiemetics",0.594,1
"Myeloablative Agonists","Myeloablative Agonists",0.594,1
"Anti-Allergic Agents","Anti-Allergic Agents",0.595,1
"Indicators and Reagents","Indicators and Reagents",0.598,1
"Contraceptives, Oral, Synthetic","Contraceptives, Oral, Synthetic",0.6,1
"Anti-Infective Agents","Anti-Infective Agents",0.613,1
"Antidepressive Agents","Antidepressive Agents",0.614,1
"Antirheumatic Agents","Antirheumatic Agents",0.614,1
"Antiparasitic Agents","Antiparasitic Agents",0.615,1
"GABA Antagonists","GABA Antagonists",0.634,1
"Antibiotics, Antineoplastic","Antibiotics, Antineoplastic",0.669,1
"Hydroxymethylglutaryl-CoA Reductase Inhibitors","Hydroxymethylglutaryl-CoA Reductase Inhibitors",0.671,1
"HIV Protease Inhibitors","HIV Protease Inhibitors",0.677,1
"Hypoglycemic Agents","Hypoglycemic Agents",0.735,1
"Muscle Relaxants, Central","Muscle Relaxants, Central",0.746,1
"Uricosuric Agents","Uricosuric Agents",0.746,1
"Antinematodal Agents","Antinematodal Agents",0.753,1
"Analgesics","Analgesics",0.755,1
"Tubulin Modulators","Tubulin Modulators",0.761,1
"Histamine H2 Antagonists","Histamine H2 Antagonists",0.773,1
"Narcotic Antagonists","Narcotic Antagonists",0.777,1
"Antineoplastic Agents, Phytogenic","Antineoplastic Agents, Phytogenic",0.784,1
"Cardiotonic Agents","Cardiotonic Agents",0.805,1
"Anticestodal Agents","Anticestodal Agents",0.806,1
"Topoisomerase I Inhibitors","Topoisomerase I Inhibitors",0.81,1
"Trypanocidal Agents","Trypanocidal Agents",0.815,1
"Intercalating Agents","Intercalating Agents",0.832,1
"Topoisomerase II Inhibitors","Topoisomerase II Inhibitors",0.834,1
"Antimetabolites","Antimetabolites",0.838,1
"Reverse Transcriptase Inhibitors","Reverse Transcriptase Inhibitors",0.838,1
"Anticholesteremic Agents","Anticholesteremic Agents",0.839,1
"Cholinesterase Inhibitors","Cholinesterase Inhibitors",0.873,1
"Nootropic Agents","Nootropic Agents",0.873,1
"Cardiovascular Agents","Cardiovascular Agents",0.892,1
"Anthelmintics","Anthelmintics",0.909,1
"Insecticides","Insecticides",0.909,1
"Anti-Infective Agents, Local","Anti-Infective Agents, Local",0.911,1
"Antipruritics","Antipruritics",0.911,1
"Antimalarials","Antimalarials",0.916,1
"Histamine H1 Antagonists, Non-Sedating","Histamine H1 Antagonists, Non-Sedating",0.938,1
